Dark Forest Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Dark Forest Capital Management’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,500	Closed	-$182K	–	1140
2023 Q1	$182K	Buy	4,500 +4,491	+49,900%	+$214K	0.04%	431
2022 Q4	$419	Buy	+9	New	+$410	﹤0.01%	1025
2022 Q2	–	Sell	-40	Closed	-$3K	–	1021
2022 Q1	$3K	Buy	+40	New	+$2.6K	﹤0.01%	1145

Other funds holding ENTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dark Forest Capital Management's ENTA Position: Q2 2023 in Review

Dark Forest Capital Management sold out of Enanta Pharmaceuticals (ENTA) in Q2 2023, closing a stake of 4,500 shares — an estimated $182K sold.

Dark Forest Capital Management first reported a position in ENTA in Q1 2022 and held it in 3 quarters. The position peaked at $182K in Q1 2023. 133 funds tracked by Wall St. Rank hold ENTA as of Q2 2023.

Dark Forest Capital Management reported no remaining Enanta Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Dark Forest Capital Management sold 4,500 Enanta Pharmaceuticals shares in Q2 2023, an estimated $182K.
Dark Forest Capital Management first reported a position in Enanta Pharmaceuticals in Q1 2022 and held it in 3 quarters.
Dark Forest Capital Management's Enanta Pharmaceuticals position peaked at $182K in Q1 2023.
133 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2023.

Based on Dark Forest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.